-
Lysoptosis: A Conserved Cathepsin-Driven Death Pathway
2026-09-01
The reference study defines lysoptosis as a conserved lysosome-dependent cell death pathway in which lysosomal membrane permeabilization releases cathepsins that drive cytoplasmic proteolysis. By comparing Caenorhabditis elegans with mouse and human epithelial models, it shows that intracellular serpins can restrain this pathway, with cathepsin L emerging as the predominant executioner in the mammalian systems examined.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-08-31
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, frozen and paraffin tissue staining, flow cytometry, and ELISA workflows. It should be paired with validated goat IgG primaries and not used as a general secondary reagent for non-goat antibodies or unvalidated targets.
-
GOB-38 in Elizabethkingia anophelis
2026-08-31
The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, by combining recombinant expression, purified-enzyme biochemistry, genomic analysis, and bacterial co-culture. Its broad hydrolysis profile and distinctive active-site residues clarify how this enzyme may contribute to β-lactam resistance while showing why biochemical results should be interpreted alongside genomic and transmission evidence.
-
Bobcat339 for Reliable Epigenetic Assays
2026-08-30
Learn how Bobcat339 (SKU BA4643) can support controlled TET1/TET2 perturbation in cell viability, proliferation, and epigenetic experiments. This scenario-based guide connects biochemical potency data with practical controls, compound handling, and interpretation of DNA methylation outcomes.
-
PDHA1 Succinylation and Immune Escape in Cholangiocarcinoma
2026-08-29
The reference study identifies PDHA1 lysine 83 succinylation as a metabolic-immune switch in cholangiocarcinoma. By increasing PDHA1 activity and promoting α-ketoglutarate accumulation, this modification activates macrophage OXGR1–MAPK signaling, suppresses MHC-II antigen presentation, and contributes to chemotherapy resistance.
-
Azithromycin B1398: Reliable Assay Workflows
2026-08-28
Azithromycin (SKU B1398) supports controlled bacterial infection research, resistance profiling, and carefully interpreted cell-based viability workflows. This scenario-driven guide explains solvent selection, stability, assay controls, and vendor evaluation using documented formulation data and peer-reviewed macrolide mechanism evidence.
-
HAUS1 in HCC: Immune Microenvironment and Prognosis
2026-08-28
The reference study identifies HAUS1 as an overexpressed, prognostically adverse marker in hepatocellular carcinoma and connects its expression with tumor biology and the immune microenvironment. By integrating public multi-omics resources with siRNA-based in vitro experiments, it provides a useful framework for evaluating HAUS1 as a biomarker and possible therapeutic target, while also highlighting the need for prospective and mechanistic validation.
-
P2RX1-Driven Mitochondrial Apoptosis in Ph+ ALL
2026-08-27
Li et al. identify P2RX1 as a mechanistic link between calcium dysregulation, CaMKII activation, PI3K/Akt suppression, and mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia. Their SUP-B15 model suggests that P2RX1 can influence tyrosine kinase inhibitor sensitivity, while also highlighting the need to distinguish prognostic association from treatment-specific cellular effects.
-
Acetylcholine Chloride in Gut–Brain Research
2026-08-27
A translational framework for using Acetylcholine Chloride to interrogate gut–vagus–brain cholinergic signaling, informed by recent findings linking Bacteroides fragilis, colonic ChAT-positive cells, vagal transmission, and seizure suppression.
-
CLK2, BRCA1, and Platinum Resistance in Ovarian Cancer
2026-08-26
The reference study identifies Cdc2-like kinase 2 (CLK2) as a contributor to platinum resistance in ovarian cancer and connects its activity to BRCA1 Ser1423 phosphorylation and DNA damage repair. Its tissue, cellular, mechanistic, and xenograft evidence supports CLK2 as a candidate resistance pathway while also highlighting the need for selective, clinically validated interventions.
-
MLKL Polymerization, Lysosomal Leakage, and Necroptosis
2026-08-26
The reference study identifies lysosomal membrane permeabilization as a critical intermediate between MLKL polymerization and necroptotic plasma membrane rupture. Its experiments place cathepsin B downstream of lysosomal disruption and show that pharmacological inhibition or genetic depletion of cathepsin B can protect cells from necroptosis.
-
SIRT1/2 Inhibitor IV (cambinol) Workflows
2026-08-25
This scenario-based guide explains how SIRT1/2 Inhibitor IV (cambinol), SKU B6063, can be incorporated into viability, proliferation, apoptosis, CNS injury, and tumor research workflows. It emphasizes concentration interpretation, DMSO and storage controls, orthogonal readouts, and vendor-selection criteria grounded in the available biochemical and in vivo data.
-
BV6 and Cell-Death Assay Design in Cancer Research
2026-08-25
BV6 is an IAP antagonist that helps researchers investigate apoptosis, therapeutic sensitization, and cell-death pathway dependence. This article develops an assay-design framework that distinguishes IAP-mediated apoptotic priming from RIPK3–MLKL necroptosis competence.
-
Polygodial in TRPA1 and Cell Assays
2026-08-24
Learn how Polygodial, SKU B7311, can support controlled TRPA1 activation studies while helping researchers distinguish ion-channel signaling from nonspecific effects in viability and cytotoxicity assays. This scenario-based guide covers assay compatibility, handling, protocol design, interpretation, and practical vendor selection.
-
α-Bungarotoxin: Blocking Signaling to Prove Mechanism
2026-08-24
α-Bungarotoxin turns cholinergic pathway observation into a testable causal model. This thought-leadership guide shows how selective α7 nAChR antagonism can strengthen neuroscience, neurotoxicity, and placental translational research while clarifying experimental limits.